Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Director/PDMR Shareholding

5 Aug 2013 17:30

RNS Number : 9414K
PZ CUSSONS PLC
05 August 2013
 

Director/PDMR Shareholding

5 August 2013

 

PZ Cussons Plc (the 'Company')

 

The Company announces that on 2 August 2013 ordinary shares of 1p each in the Company were transferred to the Executive Directors of the Company and certain persons discharging managerial responsibility ('PDMRs') by the Paterson Zochonis Employee Trust ('the Trust') in relation to deferred awards made in 2010 under the Company's Deferred Annual Share Bonus Scheme ('DASBS'). The shares have been held in trust for three years and have been released in accordance with the rules of the DASBS.

UK residents pay tax and National Insurance at the time the shares are transferred. The Executive Directors and PDMRs sold the number of shares listed below for a price of £3.9010 per share to discharge their tax obligations arising from the release of the shares.

 

Executive Director

Number of shares awarded under the DASBS

Number of shares sold to discharge tax liability

Payment made to discharge tax liability

Total shares released to certificate

 

Number of shares held in the Company following the award

Total beneficial interest

Mr G A Kanellis

85,380

40,129

-

45,251

483,794

0.11%

Mr C G Davis

54,600

-

£100,107

54,600

323,677

0.08%

Mr B H Leigh

53,610

25,197

-

14,206

100,228

0.02%

 

 

On the same day, Mr Leigh sold 14,207 ordinary shares to the Trust for a consideration of £3.9010 per share.

 

 

 

PDMR

Number of shares awarded under the DASBS

Number of shares sold to discharge tax liability

Total shares released to certificate

 

Number of shares held in the Company following the award

Total beneficial interest

Ms E Birchall

21,340

10,030

11,310

19,659

0.004%

Mr S Plant

16,070

7,553

6,017

24,745

0.006%

Mr A N Simonsz

19,570

9,198

10,372

37,751

0.009%

 

On the same day, Mr Plant sold 2,500 ordinary shares to the Trust for a consideration of £3.9010 per share.

 

On the same day, Mr Davis exercised options granted to him under the Company's Executive Share Option Scheme over 71,070 ordinary shares of 1p in the Company at the exercise price of £1.407 per share.

 

Mr Davis sold 71,070 ordinary shares to the Trust for a consideration of £3.9010 per share.

 

No new shares have been issued in respect of the dealings above.

The Trust is a discretionary trust under which the class of beneficiaries who may benefit comprises all bona fide employees and former employees of the Company and its subsidiaries including members of such employees' and former employees' immediate families. Accordingly, the Executive Directors and PDMRs of the Company are included in the class of beneficiaries and are deemed to have an interest in all of such shares. Subsequent to the above dealings, the Trust's holding in the ordinary shares of 1p in the Company is 3,602,499 shares (0.84%).

 

Name of contact and telephone number for queries:

Sam Plant

Company Secretary, PZ Cussons Plc, (T) (00) 44 (0)161 435 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPAMLTMBMMMRJ
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.